These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11347053)

  • 41. [Adrenal diseases and lipid metabolism].
    Miyachi Y
    Nihon Rinsho; 1983 Aug; 41(8):1861-5. PubMed ID: 6632297
    [No Abstract]   [Full Text] [Related]  

  • 42. NITROGEN metabolism in Cushing's syndrome.
    Nutr Rev; 1953 Feb; 11(2):38-9. PubMed ID: 13037145
    [No Abstract]   [Full Text] [Related]  

  • 43. The pattern of intermediary carbohydrate metabolism in Cushing's syndrome.
    HENNEMAN DH; BUNKER JP
    Am J Med; 1957 Jul; 23(1):34-45. PubMed ID: 13444289
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical and experimental studies on Cushing's syndrome and steroid myopathy. 1. Clinical study].
    Saiki S
    Nihon Naibunpi Gakkai Zasshi; 1966 Oct; 42(7):774-80. PubMed ID: 6008078
    [No Abstract]   [Full Text] [Related]  

  • 45. A study on the metabolism of calcium in the hyperadrenocortical syndrome.
    MOLINATTI GM; CAMANNI F; OLIVETTI M
    Acta Endocrinol (Copenh); 1960 Jul; 34():323-34. PubMed ID: 14423365
    [No Abstract]   [Full Text] [Related]  

  • 46. Cushing's Syndrome and Cardiovascular Risk.
    Anagnostis P; Goulis DG
    Curr Vasc Pharmacol; 2020; 18(1):25-26. PubMed ID: 30939868
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hyperlipidemia and glucocorticoid].
    Shimojo M; Miyachi Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():220-2. PubMed ID: 11347062
    [No Abstract]   [Full Text] [Related]  

  • 48. [Abnormal sugar metabolism in diseases of mesencephalon and pituitary gland].
    Taminato T; Seino Y; Imura H
    Nihon Rinsho; 1982 Feb; 40(2):398-401. PubMed ID: 7087219
    [No Abstract]   [Full Text] [Related]  

  • 49. [Approaches in clinical management of metabolic syndrome. 2. Keypoints in testing for lipid metabolism anomalies and cardiovascular risk].
    Kugiyama K
    Nihon Naika Gakkai Zasshi; 2004 Apr; 93(4):683-9. PubMed ID: 15174713
    [No Abstract]   [Full Text] [Related]  

  • 50. [The disturbance of lipid metabolism in the elderly].
    Saito Y
    Nihon Ronen Igakkai Zasshi; 1992 Mar; 29(3):169-73. PubMed ID: 1593785
    [No Abstract]   [Full Text] [Related]  

  • 51. Hyperlipidaemia and cardiovascular disease.
    Dominiczak MH
    Curr Opin Lipidol; 2002 Jun; 13(3):343-5. PubMed ID: 12045405
    [No Abstract]   [Full Text] [Related]  

  • 52. [Disturbance of lipid metabolism in patients with liver diseases].
    Hyogo H; Tazuma S
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():412-6. PubMed ID: 17824063
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hyperlipemia and its etiology].
    Yamamura Y
    Nihon Hifuka Gakkai Zasshi; 1972 Sep; 82(9):749. PubMed ID: 4539968
    [No Abstract]   [Full Text] [Related]  

  • 54. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
    Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
    Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cardiovascular diseases and lipid abnormalities in Cushing's syndrome].
    Luton JP; Richard C; Laudat MH; Pinon JC; Bricaire H
    Nouv Presse Med; 1982 Sep; 11(36):2693-8. PubMed ID: 7145656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Secondary hyperlipidemia due to endocrine disorders].
    Yoshino G; Maeda E
    Nihon Rinsho; 1990 Nov; 48(11):2565-71. PubMed ID: 2270022
    [No Abstract]   [Full Text] [Related]  

  • 58. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?
    Fallo F; Sonino N
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):768-71. PubMed ID: 19508589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lipid metabolism in Cushing's syndrome].
    Yoshida C; Miyachi Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():177-80. PubMed ID: 11347053
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.